Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Becton Dickinson (BDX – Research Report), Gilead Sciences (GILD – Research Report) and Merck & Company (MRK – Research Report).
Becton Dickinson (BDX)
Morgan Stanley analyst Drew Ranieri maintained a Buy rating on Becton Dickinson today and set a price target of $295.00. The company’s shares closed last Friday at $246.77.
According to TipRanks.com, Ranieri is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Becton Dickinson with a $274.78 average price target, representing a 10.5% upside. In a report released yesterday, Evercore ISI also maintained a Buy rating on the stock with a $280.00 price target.
See today’s best-performing stocks on TipRanks >>
Gilead Sciences (GILD)
SVB Securities analyst David Risinger maintained a Hold rating on Gilead Sciences today and set a price target of $91.00. The company’s shares closed last Friday at $84.68, close to its 52-week high of $89.74.
According to TipRanks.com, Risinger is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Gilead Sciences with a $91.53 average price target, which is an 8.1% upside from current levels. In a report issued on January 24, Morgan Stanley also maintained a Hold rating on the stock with a $80.00 price target.
Merck & Company (MRK)
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company, with a price target of $99.00. The company’s shares closed last Friday at $102.96.
According to TipRanks.com, Flynn is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merck & Company with a $118.13 average price target, which is a 14.4% upside from current levels. In a report issued on January 31, UBS also maintained a Hold rating on the stock with a $108.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BDX:
